The benchmark snapped a four-day losing streak on Thursday, as ⁠investors digested the European Central Bank's rate hike and largely looked...

Hyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...

European markets saw a rise on Tuesday. Banking stocks led the gains, with Italian lenders drawing attention. Tech stocks stabilized after ...

Novo Holdings is investing 500 million euros in the new Scaleup Europe Fund. This pan-European fund aims to support technology companies th...

European shares climbed Tuesday, led by technology stocks boosted by strong forecasts from STMicroelectronics amid AI demand. Investors awa...

Pfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...

European shares were muted on Tuesday as investors braced for a week packed with central bank meetings and corporate earnings, while weighi...

Sun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...

Soleno Therapeutics has withdrawn its European drug application. This decision stems from its acquirer, Neurocrine Biosciences, prioritizin...

America is set to impose hefty 100% tariffs on imported medicines. This move targets drug companies that do not agree to government pricing...

European shares were flat in early trade on Wednesday, as gains led by healthcare stocks following drugmaker Novo Nordisk's strong earnings...

The European Medicines Agency said it would review data, including results from an ongoing study, for the vaccine - known as Comirnaty. It ...

"Lower generic penetration in Italy, Spain, Portugal and France offers future growth potential as share of generics improves," the company ...

Pfizer is seeking to acquire Britain's second-biggest drugmaker and may have to sweeten its offer after AstraZeneca rejected the bid.

Net sales grew by 23.57% to Rs 1,741.7 crore during the second quarter from Rs 1,409.4 cr in the same period last fiscal.

India’s Shantha Biotech is on the block, with European drugmakers GlaxoSmithKline and Sanofi-Aventis in separate talks to buy out its Franc...

Colleen Cheng and Angel Chen, Chinese marketing executives in their 30s, should be the ideal customers for US and European drugmakers.